^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

Alkylating agent

Related drugs:
2d
The half effective concentration of TCI of cyclophosphamide in patients with neoadjuvant chemotherapy for breast cancer during intubation (ChiCTR2600119625)
P=N/A, N=50, The Affiated Cancer Hospital of Guizhou Medical University; The Affiated Cancer Hospital of Guizhou Medical University
New trial • Intubation
|
cyclophosphamide • Sufenta (sufentanil)
2d
Clinical Study on the Mobilization of Peripheral Blood Stem Cells Using the Etoposide combined with Cyclophosphamide (EC) Regimen (ChiCTR2600117978)
P2, N=40, The FIrst Affiliated Hospital, College of Medicine, Zhejiang University; The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
New P2 trial
|
cyclophosphamide • etoposide IV
3d
Pulmonary nodules in a case of microscopic polyangiitis: a case report and review of the literature. (PubMed, J Med Case Rep)
This case highlights the critical need for accurate differentiation of pulmonary nodules in MPA patients, ensuring timely and appropriate treatment.
Journal
|
MPO (Myeloperoxidase)
|
cyclophosphamide
3d
Erjing Wan ameliorates busulfan-induced oligoasthenospermia in mice by inhibiting p38 MAPK/NF-κB pathway (PubMed, Zhongguo Zhong Yao Za Zhi)
In conclusion, EJW extracts ameliorate Bu-induced oligoasthenospermia by inhibiting the p38 MAPK/NF-κB signaling pathway and mitigating testicular oxidative stress and inflammatory responses. The active material basis is likely associated with flavonoids and steroidal saponins in the alcohol extract, as well as polysaccharides.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta)
|
busulfan
3d
Senolytics alleviate cyclophosphamide-induced premature ovarian insufficiency by eliminating senescent cells. (PubMed, Eur J Histochem)
Given that chemotherapy induces cellular senescence, we investigated the therapeutic potential of dasatinib (D) and quercetin (Q), a senolytic combination known to eliminate senescent cells. RNA sequencing analysis revealed that DQ treatment upregulated Pagr1a, a gene associated with extraembryonic development, while downregulating genes involved in senescence induction (Itgb3, Wnt10b, Vegfa) and immune function (A2m, Ccl21d). These results suggest that senescent cells drive CY-induced ovarian damage and that DQ represents a promising therapeutic strategy for preserving the ovarian reserve and endocrine function in female cancer patients.
Journal
|
ITGB3 (Integrin Subunit Beta 3)
|
dasatinib • cyclophosphamide
3d
Triple-negative breast cancer with neurofibromatosis type 1: management challenges. (PubMed, BMJ Case Rep)
She underwent bilateral mastectomy with right sentinel lymph node biopsy (SLNB), followed by adjuvant docetaxel-cyclophosphamide chemotherapy. At more than 3 years of follow-up, she remains disease-free with satisfactory cosmetic outcomes. This case highlights the importance of vigilant breast surveillance in NF1, challenges in balancing oncologic control with treatment-related risks, and the need for individualised multidisciplinary care.
Journal
|
NF1 (Neurofibromin 1)
|
docetaxel • cyclophosphamide
3d
New trial
|
CD34 (CD34 molecule)
|
melphalan • thiotepa
4d
Chronic Study on the Environmentally Relevant Concentration of Cytotoxic Drug Cyclophosphamide on the Biochemical Responses of the Freshwater Mussel Lamellidens marginalis. (PubMed, Appl Biochem Biotechnol)
A noteworthy decrease (p ≤ 0.005) in antioxidant activity was obtained in 0.5 and 5.0 µg/L of CP concentration. Overall, the present findings reveal that increased concentration of CP alters antioxidant defence mechanisms in Lamellidens marginalis.
Journal
|
CAT (Catalase)
|
cyclophosphamide
4d
Linkage Between miR-218-2 (rs11134527) Genetic Polymorphism and Breast Cancer Risk: A Case-Control Study in the Bangladeshi Women. (PubMed, Health Sci Rep)
Chemotherapy was the principal treatment (62.12%), with cyclophosphamide (69.62%), doxorubicin (53.80%), and paclitaxel (56.33%) as the most prescribed agents. Significant associations were also observed under the recessive model (AA vs. GG + AG: OR = 1.96, 95% CI = 1.0-3.86, p = 0.051) and the allelic model (A vs G: OR = 1.59, 95% CI = 1.06-2.39, p = 0.026). The miR-218-2 rs11134527 A allele confers an increased risk of breast cancer in Bangladeshi women, supporting its potential role as a population-specific genetic biomarker for susceptibility assessment.
Journal
|
MIR218 (MicroRNA 218)
|
paclitaxel • doxorubicin hydrochloride • cyclophosphamide
4d
C3 Glomerulonephritis Associated With Anti-complement Factor B Antibodies Following Anti-cancer Treatment With Pembrolizumab. (PubMed, Kidney Med)
Despite treatment with corticosteroids, plasma exchange, cyclophosphamide and eculizumab he remained dialysis-dependent. PD-1 inhibitors, such as pembrolizumab, are known to predispose to loss of tolerance and generation of autoantibodies. In this case, factor B autoantibodies were detected in association with C3GN.
Journal
|
CFB (Complement Factor B)
|
Keytruda (pembrolizumab) • cyclophosphamide
4d
Protective effect of Rosmarinus officinalis L. extract against cyclophosphamide-induced testicular toxicity in rats. (PubMed, Clin Exp Reprod Med)
Although Bax expression was reduced, the decrease was not statistically significant. In conclusion, RE appears to provide protection against CYC-induced testicular injury.
Preclinical • Journal • IO biomarker
|
BAX (BCL2-associated X protein)
|
cyclophosphamide